An Adaptive in Silico Immunogenicity Prediction Platform

Time: 11:00 am
day: Day 1 Track A AM

Details:

• De-immunization effort for the mitigation of immunogenicity risk using in silico analysis
• Emulating immune response in patients using computational tools
• Integrative approach to improve the predictability of immunogenicity assessment

Speakers:

Konstantin Piatkov Konstantin Piatkov, Group Lead, Immunogenicity, Global DMPK Oncology and Rare Diseases, Takeda Pharmaceuticals, will explain why developing predictive computational approaches is key to success in Read more